چاپ صفحه |  صفحه نخست سامانه |  نویسندگان |  اطلاعات تفضیلی |  دانلود مقاله | دانشگاه علوم پزشکی تبریز |
| نویسنده | نفر چندم مقاله |
|---|---|
| محمد رضا اردلان | اول |
| سپیده زنونی واحد | دوم |
| عنوان | متن |
|---|---|
| خلاصه مقاله | Glucocorticoids (GCs) therapy is a selective treatment strategy for cases with nephrotic syndrome (NS). Due to the lack of positive response of all patients to therapy and the dependency of biological effects of GCs on its receptors (GR), here, the association of the NR3C1 gene (N363S, Bclİ, GR-9β, and ER22/23EK) polymorphisms with the response to GCs was investigated in patients with NS. İn this study, 55 patients with primary NS including 29 steroid-responder (SS) and 26 steroid-resistant (SR) and 30 healthy individuals were recruited. The polymorphisms of NR3C1 gene were studied by PCR and sequencing of the amplified fragments and the results were compared between the groups. A3669 SNP was observed in 8.7% (n=2) of patients with SRNS and 6.3% (n=2) of responders (P=0.560). İn 40.7% of steroid-responsive patients (n=11) and 21.4% of patients with SRNS (n=6), BClİ polymorphism was detected that was not statistically significant (P=0.098). The N363S and ER22/23EK polymorphisms were not detected in the studied groups. No significant differences were observed between the frequency of the studied polymorphisms between the different subtypes of NS; focal segmental glomerulosclerosis (FSGS), membranous glomerulonephritis (MGN), and control group. The NR3C1 gene N363S, Bclİ, GR-9β, and ER22/23EK polymorphisms did not affect the steroid responsiveness and the pathogenesis of NS in Azarian adult patients with primary NS. Other polymorphisms within NR3C1 gene need to be explored in large cohorts. |
| کلمات کلیدی | NR3C1, GENE POLYMORPHISM, FOCAL SEGMENTAL GLOMERULOSCLEROSIS, MEMBRANOUS GLOMERULONEPHRITIS |
| نام فایل | تاریخ درج فایل | اندازه فایل | دانلود |
|---|---|---|---|
| NR3C1 GENE POLYMORPHISMS IN.pdf | 1400/10/06 | 232484 | دانلود |
| X.pdf | 1400/08/24 | 10242497 | دانلود |
